Royalty Pharma: Key Strategic Updates To Be Priced In

Stock Performance - Royalty Pharma plc (NASDAQ: RPRX) stock price increased by more than 16% following a Strong Buy suggestion in early November 2024, outperforming the S&P 500 change [1] Analyst Position - The analyst has a beneficial long position in RPRX shares through stock ownership, options, or other derivatives [2] Disclosure Information - The article expresses the analyst's own opinions and is not receiving compensation other than from Seeking Alpha [2] - Seeking Alpha's analysts are third-party authors, including both professional and individual investors, who may not be licensed or certified by any institute or regulatory body [3]